Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Samir Kapadia MD

Samir R. Kapadia MD

Section Head, Interventional Cardiology; Director, Sones Cardiac Catheterization Laboratories; Program Director, Interventional Cardiology Fellowship; Interventional Cardiologist, Cleveland Clinic, Cleveland, Ohio

2015-present     Section head, Interventional Cardiology, Cleveland Clinic

2009-present     Director, Sones Cardiac Catheterization Laboratories, Cleveland Clinic

2005-present     Program Director, Interventional Cardiology Fellowship, Cleveland Clinic

2003-present     Interventional Cardiologist, Cleveland Clinic

Disclosures

Dr. Kapadia is an unpaid member of the Steering Committee for PARTNER 3, REPRISE III and PORTICO valve trials.

Recent Contributions to PracticeUpdate:

  1. Concomitant LAAO and TAVR Among Patients With Atrial Fibrillation
  2. Prognostic Implications of Cardiac Damage Classification Based on Computed Tomography in Severe Aortic Stenosis
  3. Alcohol Septal Ablation to Prevent LVOT Obstruction During Transcatheter Mitral Valve Replacement
  4. TAVR in the Cath Lab vs Hybrid Operating Room
  5. 2017 ACC Expert Consensus Decision Pathway for TAVR in the Management of Adults With Aortic Stenosis

Most Read This Week

Recently Updated